Načítá se...
Evaluating the cost-effectiveness of biologic treatments for psoriatic arthritis: can we make better use of patient data registries?
The primary aim of this study is to explore the extent to which registry data may fulfill the evidence requirements of cost-effectiveness analysis (CEA) studies evaluating biologic therapies for the treatment of psoriatic arthritis (PsA), where trial data are lacking or insufficient. In addition, th...
Uloženo v:
| Vydáno v: | Clin Rheumatol |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer London
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5519654/ https://ncbi.nlm.nih.gov/pubmed/28612241 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10067-017-3703-9 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|